Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LYEL compared with SPTX: revenue, margins and what each company keeps, and the suppliers and customers both name
LYEL
Lyell Immunopharma, Inc.
Change
Mkt cap
Revenue
Revenue
SPTX
Seaport Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LYEL
Lyell Immunopharma, Inc.
vs
SPTX
Seaport Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
LYEL: latest quarter is a loss; flow not drawable. SPTX: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LYEL, solid
SPTX, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LYEL
11
—
City of Hope Comprehensive Cancer Center
unlisted
supplier
—
Dana Farber Cancer Institute
unlisted
supplier
—
Innovative Cellular Therapeutics Holdings Limited and Innovative Cellular Therapeutics, Inc. (together, ICT)
unlisted
supplier
—
Miltenyi CliniMACS PRODIGY ®
unlisted
supplier
7 more · LYEL chain
›
Shared
0
No disclosed counterparties: SPTX.
Only SPTX
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
LYEL
Lyell Immunopharma, Inc.
Change
10.96
· pre 10.96
· delayed
Mkt cap
$270.5M
Revenue
$4,000
Q2 FY26
Revenue
$36,000
FY25
SPTX
Seaport Therapeutics, Inc.
Change
19.58
· pre 19.99
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$690.6M
Revenue
—
Revenue
—
vs
Compare
Pre-market
Oct 30 '26
delayed
LYEL
Lyell Immunopharma, Inc.
vs
SPTX
Seaport Therapeutics, Inc.
10.96
pre 10.96
delayed
Price
19.58
pre 19.99
delayed
$270.5M
Mkt cap
$690.6M
Q2 FY26
$4,000
Revenue
—
FY25
$36,000
Revenue
—
Change
Change
LYEL
10.96
vs
SPTX
19.58
Pre-market
Oct 30 '26
delayed